10times
16 Sep 2020

A Comprehensive Approach to Assess the Impact of Microbial Impurities on Patient Safety and Product Quality of Biologics

About 2SpeakersExhibitorsReviewsPhotos

Timings

09:00 AM - 06:00 PM
Not Verified

Official Links

Estimated Turnout

upto 100
Delegates

Editions

16 Sep 2020

Frequency

Newly Listed
Claim event to edit details

A Comprehensive Approach to Assess the Impact of Microbial Impurities on Patient Safety and Product Quality of Biologics, large-scale Production of .. Read more Biologics is susceptible to microbial contamination because many manufacturing steps occur under non-sterile conditions in aqueous systems at ambient temperature or 2-8 °C under substantially neutral pH conditions. Regardless of where in the Drug Substance manufacture, or Drug Product manufacture they occur, microbial contaminations can have a significant impact on product quality and patient safety.

Speaker
Dr Friedrich von Wintzingerode

Dr Friedrich von Wintzingerode

QC Lead iNeST Project
Speaker
Shabnam Solati

Shabnam Solati

CEO & Co-Founder
  • Share your Experience
  • Organizer
Logo Follow Company

BIOPHARMA ASIA MAGAZINE

South Korea 50 Total Events / 30 Upcoming Events

More Events From The Organizer